A Comparison Of The Attitudes About Legalization Of Marijuana Use For Medical Purposes By Cancer Patients In Two Cancer Centers Located In A Legalized And A Non-Legalized State
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03360799|
Recruitment Status : Active, not recruiting
First Posted : December 4, 2017
Last Update Posted : August 6, 2018
The goal of this research study is to learn about and compare the attitudes that patients in non-legalized and legalized states have towards the legalization of medical marijuana.
This is an investigational study.
Up to 202 participants will be enrolled in this study. Up to 102 will take part at MD Anderson.
|Condition or disease||Intervention/treatment|
|Malignant Neoplasms of Independent (Primary) Multiple Sites||Behavioral: Questionnaires|
If you choose to take part in this study, you will complete 5 questionnaires which will ask for your demographic information (age, race, sex, and so on) and about your feelings towards doctors, the use of marijuana (including your own personal use), any religious or spiritual feelings that you may have, and about any anxiety and depression you may have experienced. These should take about 20-25 minutes to complete. You may complete the questionnaires on a hard copy survey or electronically on a tablet provided by the research staff. Surveys will not be e-mailed to you.
If you are unable to complete the study questionnaires during this clinic visit, you will be called by the research coordinator to complete them within 1 week. Your phone number will be collected to contact you and will be deleted after you complete the questionnaires.
All questionnaire responses will be anonymous. No personally identifying information will be linked to your responses.
Your participation on this study will be over after you complete the questionnaires.
|Study Type :||Observational|
|Actual Enrollment :||101 participants|
|Official Title:||A Comparison Of The Attitudes About Legalization Of Marijuana Use For Medical Purposes By Cancer Patients In Two Cancer Centers Located In A Legalized And A Non-Legalized State|
|Actual Study Start Date :||November 17, 2017|
|Estimated Primary Completion Date :||July 2019|
|Estimated Study Completion Date :||July 2019|
Medical Marijuana Questionnaire
Participants (inpatient or outpatient) seen by the Palliative Care team at Banner MD Anderson or UT MD Anderson.
Participants complete 5 questionnaires which ask for demographic information (age, race, sex, and so on) and about participants feelings towards doctors, the use of marijuana (including participant's own personal use), any religious or spiritual feelings that participant may have, and about any anxiety and depression participant may have experienced. These should take about 20-25 minutes to complete.
Other Name: Surveys
- Proportion of Cancer Participants Who Have a Positive Attitude About Legalizing Marijuana for Medical Purposes [ Time Frame: 1 day ]Number of subjects with positive attitude towards legalizing medical marijuana compared between participants from Texas and Arizona States using one-sided Fisher's exact test or chi-squared test.
- Evaluation of Participant's Belief in the Usefulness of Medical Marijuana [ Time Frame: 1 day ]
Participant's belief in the usefulness of medical marijuana evaluated between those who are residents of Texas versus Arizona.
Objective addressed by evaluating question 5 in the Marijuana Survey for Patients. Those who answer "Completely Agree" or "Slightly Agree" considered as positive believers. The proportion of patients with positive belief reported with a 95% confidence interval. Fisher's exact test applied to compare the proportion between residents of two states.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03360799
|United States, Arizona|
|Banner MD Anderson Cancer Center|
|Gilbert, Arizona, United States, 85234|
|United States, Texas|
|University of Texas MD Anderson Cancer Center|
|Houston, Texas, United States, 77030|
|Principal Investigator:||Kimberson C. Tanco, MD||M.D. Anderson Cancer Center|